Kowa Pharmaceuticals America, Inc. With its headquarters in Montgomery, Alabama, the company is dedicated to the development and commercialization of safe and effective pharmaceutical products. Established in 2008, Kowa Pharmaceuticals America focuses on the successful launch of its current and upcoming portfolio of healthcare solutions.

Kowa Pharmaceuticals is a subsidiary of Kowa Company, Ltd., a multinational company based in Nagoya, Japan. Founded in 1894, Kowa is actively involved in various sectors including pharmaceuticals, life science, IT, textiles, machinery, and consumer products. Kowa's pharmaceutical division focuses on research and development in cardiovascular therapeutics, ophthalmology, and anti-inflammatory agents.

Their flagship product, LIVALO® (pitavastatin), is approved in 45 countries worldwide. At Kowa Pharmaceuticals, their management team is dedicated to innovation, consistency, and quality in serving physicians and patients. The company's board of directors ensures stable and sustained growth for the organization.

For more information about Kowa Pharmaceuticals America, Inc